Personal information

skin on chip, heart on chip, diabetes, ALS, stem cells, genetic, gene therapy
Spain, United States

Biography

PhD in Genetic and Development by the University of Zaragoza and Professor in Human Anatomy and Histology department at the same university. He joined CIBER-BBN in late 2012, to work as a researcher of the NanoBioCel Group at the UPV/EHU and moved later in 2020 to work at the Instituto de Investigación en Ingeniería de Aragón (I3A). He has previously worked on stem cell microencapsulation involving: optimization of stem cell microencapsulation techniques, study of new materials for stem cell microencapsulation and preclinical translation of microencapsulated stem cells among others. He has postdoctoral experience on gene therapy, neurodegenerative diseases, DNA vaccines, pancreatic islet isolation, differentiation of embryonic stem cells into insulin producing cell and kidney capsule transplantation on induced diabetic mice. Currently he is interested in modeling and understanding the interactions between cells and with their microenvironment in physiological and pathophysiological conditions to find new personalized therapeutic strategies. His recent research lines are focused on skin on chip and heart on chip models.

Activities

Employment (5)

University of Zaragoza: Zaragoza, Non United States Or Canada, ES

2022-11-20 to present | Professor (Human Anatomy and Histology)
Employment
Source: Self-asserted source
Jesus Ciriza

Centro de Investigación Biomédica en Red: Madrid, Spain, ES

2013 to 2022
Employment
Source: Self-asserted source
Jesus Ciriza

University of California, Merced: Merced, CA, US

2007 to 2012
Employment
Source: Self-asserted source
Jesus Ciriza

Universidad Publica de Navarra: Pamplona, ES

2006 to 2007
Employment
Source: Self-asserted source
Jesus Ciriza

Universidad de Zaragoza: Zaragoza, ES

2000 to 2004
Employment
Source: Self-asserted source
Jesus Ciriza

Education and qualifications (4)

University of Zaragoza: Zaragoza, Non United States Or Canada, ES

2004-04 | PhD in Genetic and Development
Education
Source: Self-asserted source
Jesus Ciriza

University of Zaragoza: Zaragoza, Non United States Or Canada, ES

2000-06 | Degree in Food Science and Technology
Education
Source: Self-asserted source
Jesus Ciriza

University of Zaragoza: Zaragoza, Non United States Or Canada, ES

1999-06 | Degree in Biochemistry
Education
Source: Self-asserted source
Jesus Ciriza

University of Zaragoza: Zaragoza, Non United States Or Canada, ES

1992-09 to 1997-06 | Degree in Chemistry
Education
Source: Self-asserted source
Jesus Ciriza

Funding (7)

3D BIOPRINTED PERSONALISED SCAFFOLDS FOR TISSUE REGENERATION OF ANKLE JOINT

2021-01-01 to 2024-12-31 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: 952981
Source: Self-asserted source
Jesus Ciriza via DimensionsWizard

Accelerating Innovation in Microfabricated Medical Devices

2020-06-01 to 2023-09-30 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: 876190
Source: Self-asserted source
Jesus Ciriza via DimensionsWizard

Computational biomechanics and bioengineering 3D printing to develop a personalized regenerative biological ventricular assist device to provide lasting functional support to damaged hearts

2020-01-01 to 2024-12-31 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: 874827
Source: Self-asserted source
Jesus Ciriza via DimensionsWizard

A pilot line for the next generation of smart catheters and implants

2018-06-01 to 2021-09-30 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: 783132
Source: Self-asserted source
Jesus Ciriza via DimensionsWizard

Diabetes Reversing Implants with enhanced Viability and long-term Efficacy

2015-06-01 to 2019-05-31 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: 645991
Source: Self-asserted source
Jesus Ciriza via DimensionsWizard

Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas diseasE

2012-09-01 to 2018-08-31 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: 305937
Source: Self-asserted source
Jesus Ciriza via DimensionsWizard

Enhancing Survival of Embryonic Stem Cell-Derived Grafts by Induction of Immunological Tolerance

2008-06-01 to 2013-05-31 | Grant
California Institute for Regenerative Medicine (San Francisco, US)
GRANT_NUMBER: RN1-00554
Source: Self-asserted source
Jesus Ciriza via DimensionsWizard